MultiCare Institute for Research and Innovation- Tacoma — Tacoma, Washington

MultiCare Institute for Research and Innovation- Tacoma is a clinical research site located in Tacoma, Washington, United States 98405.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

MultiCare Institute for Research and Innovation- Tacoma has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease.

Sponsors: NewAmsterdam Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tacoma

Browse all research sites in Washington · View every site in Tacoma

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MultiCare Institute for Research and Innovation- Tacoma?

MultiCare Institute for Research and Innovation- Tacoma has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MultiCare Institute for Research and Innovation- Tacoma conducted?

MultiCare Institute for Research and Innovation- Tacoma has 1 clinical trials on record, with 1 currently active. Their work covers Atherosclerotic Cardiovascular Disease.

Is MultiCare Institute for Research and Innovation- Tacoma accredited by Crixeo Clinical Trials?

MultiCare Institute for Research and Innovation- Tacoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MultiCare Institute for Research and Innovation- Tacoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.